论文部分内容阅读
作者分别用西地兰、三磷酸隙苷(ATP)和异搏停共治62例发作的117次阵发性室上性心动过速(PSVT)。西地兰按0.02～0.04m g/kg 静注:ATP 的剂量小于1岁者为3～5mg/次,随年龄递增最多可用至15mg/次,5秒钟内静脉注入,异搏停按0.125～0.250mg/kg 计,最多不超过5mg,用生理盐水稀释,其半量在5秒钟内静脉注入,用心电图观察1分钟,若心动过速不止或心动周期未见延长,再将余下的半量在1分钟内静脉注完。结果发现 ATP 或异搏停治疗的成功率达90%左右,西地兰仅61～71%。给 ATP 后1分钟内心动过速可终止,异搏停在大多数病例亦可在2分钟内奏效,西地兰则需2小时左右.
The authors co-treated 62 patients with paroxysmal supraventricular tachycardia (PSVT) with cedilanid, triphosphate (ATP) and verapamil respectively. Cedilanid 0.02-0.04mg / kg intravenous injection: ATP dose of less than 1 year old for the 3 ~ 5mg / times, with age up to 15mg / time available, 5 seconds intravenous injection, verapamil 0.125 ~ 0.250mg / kg total, not more than 5mg, diluted with saline, the half amount of intravenous infusion within 5 seconds, with ECG observed for 1 minute, if more than tachycardia or cardiac cycle was not extended, and then the remaining half of the amount of 1 minute intravenous injection finished. The results showed that ATP or verapamil treatment success rate of about 90%, cedilanid only 61 ~ 71%. Tachycardia can be terminated within 1 minute of giving ATP, stopping bleeding in most cases can be effective within 2 minutes, cedilanid takes about 2 hours.